These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23731989)

  • 21. A clinically relevant approach to imaging prostate cancer: review.
    Verma S; Rajesh A
    AJR Am J Roentgenol; 2011 Mar; 196(3 Suppl):S1-10 Quiz S11-4. PubMed ID: 21343529
    [No Abstract]   [Full Text] [Related]  

  • 22. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
    Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
    AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic contrast-enhanced MR imaging in the evaluation of patients with prostate cancer.
    McMahon CJ; Bloch BN; Lenkinski RE; Rofsky NM
    Magn Reson Imaging Clin N Am; 2009 May; 17(2):363-83. PubMed ID: 19406364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in pediatric oncology MRI.
    Olsen ØE
    Acta Radiol; 2013 Nov; 54(9):1030-6. PubMed ID: 23873884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of MRI in the localization, staging, volume estimation, assessment of aggressiveness, and guidance of radiotherapy and biopsies in prostate cancer.
    Yakar D; Debats OA; Bomers JG; Schouten MG; Vos PC; van Lin E; Fütterer JJ; Barentsz JO
    J Magn Reson Imaging; 2012 Jan; 35(1):20-31. PubMed ID: 22174000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
    Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
    J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.
    Quentin M; Arsov C; Röhlen S; Klasen J; Antoch G; Albers P; Blondin D
    Rofo; 2012 Oct; 184(10):925-9. PubMed ID: 22744328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update of prostate magnetic resonance imaging at 3 T.
    Kim CK; Park BK
    J Comput Assist Tomogr; 2008; 32(2):163-72. PubMed ID: 18379296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance imaging of prostate cancer.
    Guneyli S; Erdem CZ; Erdem LO
    Clin Imaging; 2016; 40(4):601-9. PubMed ID: 27317204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical utility of diffusion-weighted magnetic resonance imaging in prostate cancer.
    Afaq A; Koh DM; Padhani A; van As N; Sohaib SA
    BJU Int; 2011 Dec; 108(11):1716-22. PubMed ID: 21631696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton spectroscopic and dynamic contrast-enhanced magnetic resonance: a modern approach in prostate cancer imaging.
    Sciarra A; Salciccia S; Panebianco V
    Eur Urol; 2008 Sep; 54(3):485-8. PubMed ID: 18439748
    [No Abstract]   [Full Text] [Related]  

  • 34. Interpretation and reporting multiparametric prostate MRI: a primer for residents and novices.
    Hedgire SS; Eberhardt SC; Borczuk R; McDermott S; Harisinghani MG
    Abdom Imaging; 2014 Oct; 39(5):1036-51. PubMed ID: 24566965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current role of MRI for the local staging of prostate cancer].
    Busquets JC; Batlle JC; Obregón JB; Ortega MV; Morell NR
    Arch Esp Urol; 2006 Dec; 59(10):1001-10. PubMed ID: 17283713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
    Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in magnetic resonance imaging: how they are changing the management of prostate cancer.
    Sciarra A; Barentsz J; Bjartell A; Eastham J; Hricak H; Panebianco V; Witjes JA
    Eur Urol; 2011 Jun; 59(6):962-77. PubMed ID: 21367519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Management: Current Status and Future Perspectives.
    Scheenen TW; Rosenkrantz AB; Haider MA; Fütterer JJ
    Invest Radiol; 2015 Sep; 50(9):594-600. PubMed ID: 25974203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MR imaging in local staging of prostate cancer.
    Fütterer JJ
    Eur J Radiol; 2007 Sep; 63(3):328-34. PubMed ID: 17689908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MR assessment of recurrent prostate cancer after radiation therapy.
    Rouvière O
    Radiology; 2007 Feb; 242(2):635-6; author reply 636-7. PubMed ID: 17255435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.